APO Research

APO RESEARCH · REPORT

Droperidol Injection

Selected research

Market Analysis & Forecast

Global Droperidol Injection Market Analysis and Forecast 2026-2032

Market perspective

The global Droperidol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Droperidol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Droperidol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Droperidol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Droperidol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Droperidol Injection include American Regent, Phebra, Beijing Yookon, Pfizer, Shandong Hualu Pharmaceutical and Shagnhai Xudong Haipu Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Droperidol Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Droperidol Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Droperidol Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Droperidol Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Droperidol Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Droperidol Injection sales, projected growth trends, production technology, application and end-user industry.

Droperidol Injection Segment by Company

American Regent

Phebra

Beijing Yookon

Pfizer

Shandong Hualu Pharmaceutical

Shagnhai Xudong Haipu Pharmaceutical

Droperidol Injection Segment by Type

2.5mg/ml

5mg/2ml

Droperidol Injection Segment by Application

Recovery Center

Hospital

Clinics

Droperidol Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Droperidol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Droperidol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Droperidol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Droperidol Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Droperidol Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Droperidol Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Droperidol Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5mg/ml Major Manufacturers Table 3. 5mg/2ml Major Manufacturers Table 4. Global Droperidol Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Recovery Center Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Droperidol Injection Industry Trends Table 9. Droperidol Injection Industry Drivers Table 10. Droperidol Injection Industry Opportunities and Challenges Table 11. Droperidol Injection Industry Restraints Table 12. Global Droperidol Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Droperidol Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Droperidol Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Droperidol Injection Revenue Market Share by Region (2021-2026) Table 16. Global Droperidol Injection Revenue Market Share by Region (2027-2032) Table 17. Global Droperidol Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Droperidol Injection Sales by Region (2021-2026) & (W Units) Table 19. Global Droperidol Injection Sales by Region (2027-2032) & (W Units) Table 20. Global Droperidol Injection Sales Market Share by Region (2021-2026) Table 21. Global Droperidol Injection Sales Market Share by Region (2027-2032) Table 22. Global Droperidol Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Droperidol Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Droperidol Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Droperidol Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Droperidol Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Droperidol Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Droperidol Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Droperidol Injection Manufacturers, Product Type & Application Table 30. Global Droperidol Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Droperidol Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Droperidol Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Droperidol Injection Revenue Market Share by Type (2021-2026) Table 37. Global Droperidol Injection Revenue Market Share by Type (2027-2032) Table 38. Global Droperidol Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 40. Global Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 41. Global Droperidol Injection Sales Market Share by Type (2021-2026) Table 42. Global Droperidol Injection Sales Market Share by Type (2027-2032) Table 43. Global Droperidol Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Droperidol Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Droperidol Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Droperidol Injection Revenue Market Share by Application (2021-2026) Table 49. Global Droperidol Injection Revenue Market Share by Application (2027-2032) Table 50. Global Droperidol Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 52. Global Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 53. Global Droperidol Injection Sales Market Share by Application (2021-2026) Table 54. Global Droperidol Injection Sales Market Share by Application (2027-2032) Table 55. Global Droperidol Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Droperidol Injection Price by Application (2027-2032) & (US$/Unit) Table 57. American Regent Company Information Table 58. American Regent Business Overview Table 59. American Regent Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. American Regent Droperidol Injection Product Portfolio Table 61. American Regent Recent Development Table 62. Phebra Company Information Table 63. Phebra Business Overview Table 64. Phebra Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Phebra Droperidol Injection Product Portfolio Table 66. Phebra Recent Development Table 67. Beijing Yookon Company Information Table 68. Beijing Yookon Business Overview Table 69. Beijing Yookon Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Beijing Yookon Droperidol Injection Product Portfolio Table 71. Beijing Yookon Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pfizer Droperidol Injection Product Portfolio Table 76. Pfizer Recent Development Table 77. Shandong Hualu Pharmaceutical Company Information Table 78. Shandong Hualu Pharmaceutical Business Overview Table 79. Shandong Hualu Pharmaceutical Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shandong Hualu Pharmaceutical Droperidol Injection Product Portfolio Table 81. Shandong Hualu Pharmaceutical Recent Development Table 82. Shagnhai Xudong Haipu Pharmaceutical Company Information Table 83. Shagnhai Xudong Haipu Pharmaceutical Business Overview Table 84. Shagnhai Xudong Haipu Pharmaceutical Droperidol Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shagnhai Xudong Haipu Pharmaceutical Droperidol Injection Product Portfolio Table 86. Shagnhai Xudong Haipu Pharmaceutical Recent Development Table 87. North America Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 90. North America Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 91. North America Droperidol Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Droperidol Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 96. North America Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 97. North America Droperidol Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Droperidol Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Droperidol Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Droperidol Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Droperidol Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 103. North America Droperidol Injection Sales by Country (2021-2026) & (W Units) Table 104. North America Droperidol Injection Sales by Country (2027-2032) & (W Units) Table 105. North America Droperidol Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Droperidol Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 108. Canada Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 109. Europe Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 112. Europe Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 113. Europe Droperidol Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Droperidol Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 118. Europe Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 119. Europe Droperidol Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Droperidol Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Droperidol Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Droperidol Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Droperidol Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 125. Europe Droperidol Injection Sales by Country (2021-2026) & (W Units) Table 126. Europe Droperidol Injection Sales by Country (2027-2032) & (W Units) Table 127. Europe Droperidol Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Droperidol Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 130. France Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 131. U.K. Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 132. Italy Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 134. Nordic Countries Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 135. China Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 136. China Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 137. China Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 138. China Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 139. China Droperidol Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Droperidol Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. China Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. China Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 144. China Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 145. China Droperidol Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Droperidol Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 150. Asia Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 151. Asia Droperidol Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Droperidol Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 156. Asia Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 157. Asia Droperidol Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Droperidol Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Droperidol Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Droperidol Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Droperidol Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 163. Asia Droperidol Injection Sales by Country (2021-2026) & (W Units) Table 164. Asia Droperidol Injection Sales by Country (2027-2032) & (W Units) Table 165. Asia Droperidol Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Droperidol Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 168. South Korea Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 169. India Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 170. Australia Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Droperidol Injection Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Droperidol Injection Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Droperidol Injection Sales by Type (2021-2026) & (W Units) Table 176. SAMEA Droperidol Injection Sales by Type (2027-2032) & (W Units) Table 177. SAMEA Droperidol Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Droperidol Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Droperidol Injection Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Droperidol Injection Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Droperidol Injection Sales by Application (2021-2026) & (W Units) Table 182. SAMEA Droperidol Injection Sales by Application (2027-2032) & (W Units) Table 183. SAMEA Droperidol Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Droperidol Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Droperidol Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Droperidol Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Droperidol Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 189. SAMEA Droperidol Injection Sales by Country (2021-2026) & (W Units) Table 190. SAMEA Droperidol Injection Sales by Country (2027-2032) & (W Units) Table 191. SAMEA Droperidol Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Droperidol Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 194. Argentina Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 195. Chile Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 196. Colombia Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 197. Peru Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 199. Israel Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 200. UAE Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 201. Turkey Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 202. Iran Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 203. Egypt Droperidol Injection Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Droperidol Injection Distributors List Table 207. Droperidol Injection Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Droperidol Injection Image Figure 2. Global Droperidol Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Droperidol Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5mg/ml Image Figure 5. 5mg/2ml Image Figure 6. Global Droperidol Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Droperidol Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Recovery Center Image Figure 9. Hospital Image Figure 10. Clinics Image Figure 11. Global Droperidol Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Droperidol Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Droperidol Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Droperidol Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Droperidol Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Droperidol Injection Sales (2021-2032) & (W Units) Figure 17. Global Droperidol Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Droperidol Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Droperidol Injection Sales YoY (2021-2032) & (W Units) Figure 20. Europe Droperidol Injection Sales YoY (2021-2032) & (W Units) Figure 21. China Droperidol Injection Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Droperidol Injection Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Droperidol Injection Sales YoY (2021-2032) & (W Units) Figure 24. Global Droperidol Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Droperidol Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Droperidol Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Droperidol Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Droperidol Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Droperidol Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Droperidol Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Droperidol Injection Sales Market Share by Type (2021-2032) Figure 33. Global Droperidol Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Droperidol Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Droperidol Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Droperidol Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Droperidol Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Droperidol Injection Sales Market Share by Application (2021-2032) Figure 39. North America Droperidol Injection Revenue Share by Type (2021-2032) Figure 40. North America Droperidol Injection Sales Share by Type (2021-2032) Figure 41. North America Droperidol Injection Revenue Share by Application (2021-2032) Figure 42. North America Droperidol Injection Sales Share by Application (2021-2032) Figure 43. North America Droperidol Injection Revenue Share by Country (2021-2032) Figure 44. North America Droperidol Injection Sales Share by Country (2021-2032) Figure 45. Europe Droperidol Injection Revenue Share by Type (2021-2032) Figure 46. Europe Droperidol Injection Sales Share by Type (2021-2032) Figure 47. Europe Droperidol Injection Revenue Share by Application (2021-2032) Figure 48. Europe Droperidol Injection Sales Share by Application (2021-2032) Figure 49. Europe Droperidol Injection Revenue Share by Country (2021-2032) Figure 50. Europe Droperidol Injection Sales Share by Country (2021-2032) Figure 51. China Droperidol Injection Revenue Share by Type (2021-2032) Figure 52. China Droperidol Injection Sales Share by Type (2021-2032) Figure 53. China Droperidol Injection Revenue Share by Application (2021-2032) Figure 54. China Droperidol Injection Sales Share by Application (2021-2032) Figure 55. Asia Droperidol Injection Revenue Share by Type (2021-2032) Figure 56. Asia Droperidol Injection Sales Share by Type (2021-2032) Figure 57. Asia Droperidol Injection Revenue Share by Application (2021-2032) Figure 58. Asia Droperidol Injection Sales Share by Application (2021-2032) Figure 59. Asia Droperidol Injection Revenue Share by Country (2021-2032) Figure 60. Asia Droperidol Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Droperidol Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Droperidol Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Droperidol Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Droperidol Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Droperidol Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Droperidol Injection Sales Share by Country (2021-2032) Figure 67. Droperidol Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Droperidol Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg/ml
  • 5mg/2ml
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • American Regent
  • Phebra
  • Beijing Yookon
  • Pfizer
  • Shandong Hualu Pharmaceutical
  • Shagnhai Xudong Haipu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Droperidol Injection Market by Type
  3. 1.2.1 Global Droperidol Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5mg/ml
  5. 1.2.3 5mg/2ml
  6. 1.3 Droperidol Injection Market by Application
  7. 1.3.1 Global Droperidol Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Recovery Center
  9. 1.3.3 Hospital
  10. 1.3.4 Clinics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Droperidol Injection Market Dynamics
  1. 2.1 Droperidol Injection Industry Trends
  2. 2.2 Droperidol Injection Industry Drivers
  3. 2.3 Droperidol Injection Industry Opportunities and Challenges
  4. 2.4 Droperidol Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Droperidol Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Droperidol Injection Revenue by Region
  3. 3.2.1 Global Droperidol Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Droperidol Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Droperidol Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Droperidol Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Droperidol Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Droperidol Injection Sales by Region
  9. 3.4.1 Global Droperidol Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Droperidol Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Droperidol Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Droperidol Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Droperidol Injection Revenue by Manufacturers
  2. 4.1.1 Global Droperidol Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Droperidol Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Droperidol Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Droperidol Injection Sales by Manufacturers
  6. 4.2.1 Global Droperidol Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Droperidol Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Droperidol Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Droperidol Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Droperidol Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Droperidol Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Droperidol Injection Manufacturers, Product Type & Application
  13. 4.7 Global Droperidol Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Droperidol Injection Market CR5 and HHI
  16. 4.8.2 2025 Droperidol Injection Tier 1, Tier 2, and Tier 3
5 Droperidol Injection Market by Type
  1. 5.1 Global Droperidol Injection Revenue by Type
  2. 5.1.1 Global Droperidol Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Droperidol Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Droperidol Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Droperidol Injection Sales by Type
  6. 5.2.1 Global Droperidol Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Droperidol Injection Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Droperidol Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Droperidol Injection Price by Type
6 Droperidol Injection Market by Application
  1. 6.1 Global Droperidol Injection Revenue by Application
  2. 6.1.1 Global Droperidol Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Droperidol Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Droperidol Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Droperidol Injection Sales by Application
  6. 6.2.1 Global Droperidol Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Droperidol Injection Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Droperidol Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Droperidol Injection Price by Application
7 Company Profiles
  1. 7.1 American Regent
  2. 7.1.1 American Regent Company Information
  3. 7.1.2 American Regent Business Overview
  4. 7.1.3 American Regent Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 American Regent Droperidol Injection Product Portfolio
  6. 7.1.5 American Regent Recent Developments
  7. 7.2 Phebra
  8. 7.2.1 Phebra Company Information
  9. 7.2.2 Phebra Business Overview
  10. 7.2.3 Phebra Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Phebra Droperidol Injection Product Portfolio
  12. 7.2.5 Phebra Recent Developments
  13. 7.3 Beijing Yookon
  14. 7.3.1 Beijing Yookon Company Information
  15. 7.3.2 Beijing Yookon Business Overview
  16. 7.3.3 Beijing Yookon Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beijing Yookon Droperidol Injection Product Portfolio
  18. 7.3.5 Beijing Yookon Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Droperidol Injection Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Shandong Hualu Pharmaceutical
  26. 7.5.1 Shandong Hualu Pharmaceutical Company Information
  27. 7.5.2 Shandong Hualu Pharmaceutical Business Overview
  28. 7.5.3 Shandong Hualu Pharmaceutical Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shandong Hualu Pharmaceutical Droperidol Injection Product Portfolio
  30. 7.5.5 Shandong Hualu Pharmaceutical Recent Developments
  31. 7.6 Shagnhai Xudong Haipu Pharmaceutical
  32. 7.6.1 Shagnhai Xudong Haipu Pharmaceutical Company Information
  33. 7.6.2 Shagnhai Xudong Haipu Pharmaceutical Business Overview
  34. 7.6.3 Shagnhai Xudong Haipu Pharmaceutical Droperidol Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shagnhai Xudong Haipu Pharmaceutical Droperidol Injection Product Portfolio
  36. 7.6.5 Shagnhai Xudong Haipu Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Droperidol Injection Market Size by Type
  2. 8.1.1 North America Droperidol Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Droperidol Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Droperidol Injection Price by Type (2021-2032)
  5. 8.2 North America Droperidol Injection Market Size by Application
  6. 8.2.1 North America Droperidol Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Droperidol Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Droperidol Injection Price by Application (2021-2032)
  9. 8.3 North America Droperidol Injection Market Size by Country
  10. 8.3.1 North America Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Droperidol Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Droperidol Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Droperidol Injection Market Size by Type
  2. 9.1.1 Europe Droperidol Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Droperidol Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Droperidol Injection Price by Type (2021-2032)
  5. 9.2 Europe Droperidol Injection Market Size by Application
  6. 9.2.1 Europe Droperidol Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Droperidol Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Droperidol Injection Price by Application (2021-2032)
  9. 9.3 Europe Droperidol Injection Market Size by Country
  10. 9.3.1 Europe Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Droperidol Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Droperidol Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Droperidol Injection Market Size by Type
  2. 10.1.1 China Droperidol Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Droperidol Injection Sales by Type (2021-2032)
  4. 10.1.3 China Droperidol Injection Price by Type (2021-2032)
  5. 10.2 China Droperidol Injection Market Size by Application
  6. 10.2.1 China Droperidol Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Droperidol Injection Sales by Application (2021-2032)
  8. 10.2.3 China Droperidol Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Droperidol Injection Market Size by Type
  2. 11.1.1 Asia Droperidol Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Droperidol Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Droperidol Injection Price by Type (2021-2032)
  5. 11.2 Asia Droperidol Injection Market Size by Application
  6. 11.2.1 Asia Droperidol Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Droperidol Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Droperidol Injection Price by Application (2021-2032)
  9. 11.3 Asia Droperidol Injection Market Size by Country
  10. 11.3.1 Asia Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Droperidol Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Droperidol Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Droperidol Injection Market Size by Type
  2. 12.1.1 SAMEA Droperidol Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Droperidol Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Droperidol Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Droperidol Injection Market Size by Application
  6. 12.2.1 SAMEA Droperidol Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Droperidol Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Droperidol Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Droperidol Injection Market Size by Country
  10. 12.3.1 SAMEA Droperidol Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Droperidol Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Droperidol Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Droperidol Injection Value Chain Analysis
  2. 13.1.1 Droperidol Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Droperidol Injection Production Mode & Process
  6. 13.2 Droperidol Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Droperidol Injection Distributors
  9. 13.2.3 Droperidol Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research